In a recent poll conducted by the National Sleep Foundation, forty-eight percent of Americans report symptoms of Insomnia on a nightly basis. With this, females more so than males, report insomnia symptoms. Adults over sixty-six years were two times more likely to report insomnia symptoms as compared to young adult respondents to the National Sleep Foundation survey. An examination of the responses summarized the impact of poor sleep quality reported on healthcare costs; $14 billion directly and $28 billion indirectly costs are incurred from healthcare services/hospital/nursing home and transportation to services/lost wages, respectfully. Overall, the Center for Disease Control, reported that 8.6 million people or 4% or the general population of Adults use sleep medications. Further, researchers have reported the high co-occurrence of sleep and psychiatric prescriptions with depression and physical disability as the most common reasons. Insomnia is the most prevalent sleep disturbances reported. The treatment pathway indicates the use of sleep hygiene, then cognitive behavioral therapy then short term medication treatment for Insomnia symptoms of difficulties of both falling asleep and staying asleep. The duration and severity of the Insomnia symptoms dictate the entry point and length of time using treatment techniques on this pathway (i.e., transient = 1-3 days; Short-term=no more than 3 weeks; Chronic=3 nights/week for one month or longer). It is estimated that nearly 25% of all Americans have transient insomnia symptoms and approximately 10% have chronic symptoms of Insomnia.